David M Ashley

16PUBLICATIONS
208CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Speciation and extinctionBiomaterialsGene and molecular therapyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 16, 2026
EGFR-targeted antibody-toxin conjugate in recurrent glioma: a phase 1 trial.

|Oct 14, 2026
Divergent genomic evolution in astrocytomas and oligodendrogliomas.

|Apr 27, 2026
Anti-VEGF vascular remodeling drives germinal center B cell-rich tertiary lymphoid structures during antibody-toxin and anti-CD40 combination therapy in glioblastoma.

|Feb 12, 2026
STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

Mark W Youngblood, Shashwat Tripathi, Hinda Najem

|Nov 21, 2025
Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration.

Andrea L Ludwig, Zachary P McKay, Griffin P Carter

|Aug 11, 2025
Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress.

Jianpeng Yu, Chen Jin, Cheng Su

Pageof 3

Frequent Collaborators

5 joint publications

Annick Desjardins

5 joint publications

Mustafa Khasraw

3 joint publications

Frederick S Varn

3 joint publications

Jason T Huse